SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513160-12-000027
Filing Date
2012-04-16
Accepted
2012-04-13 18:15:26
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT pharmos10q033112.htm 10-Q 343507
2 RULE 13A-14(A)/15D-14(A) CERTIFICATION ex311.htm EX-31.1 9434
3 RULE 13A-14(A)/15D-14(A) CERTIFICATION ex312.htm EX-31.2 8531
4 SECTION 1350 CERTIFICATION ex321.htm EX-32.1 5231
5 SECTION 1350 CERTIFICATION ex322.htm EX-32.2 4991
  Complete submission text file 0001513160-12-000027.txt   1028821

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pars-20120331.xml EX-101.INS 55026
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pars-20120331.xsd EX-101.SCH 9360
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pars-20120331_cal.xml EX-101.CAL 18198
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pars-20120331_lab.xml EX-101.LAB 76053
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pars-20120331_pre.xml EX-101.PRE 48600
Mailing Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830
Business Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830 7324529556
PHARMOS CORP (Filer) CIK: 0000713275 (see all company filings)

IRS No.: 363207413 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-11550 | Film No.: 12759603
SIC: 2834 Pharmaceutical Preparations